BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 964399)

  • 41. Vaginal pH effects caused by OCs and various copper and inert IUDs.
    Kandil O; Hassanein MK; El-tagi A; El-shirbini MT
    Contracept Deliv Syst; 1983 Jul; 4(3):187-93. PubMed ID: 12265361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of copper intrauterine contraceptive devices (Cu-7-IUD) on the menstrual blood-loss.
    Larsson B; Hamberger L; Rybo G
    Acta Obstet Gynecol Scand; 1975; 54(4):315-8. PubMed ID: 1199700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of subclinical abortion in infertile women by beta-hCG radioimmunoassay.
    Onoue T; Nagata Y; Kusuda M
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Aug; 33(8):1255-8. PubMed ID: 7276652
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Premature onset of menstrual bleeding during ovulatory cycles in women with an intrauterine contraceptive device.
    Nygren KG; Johansson ED
    Am J Obstet Gynecol; 1973 Dec; 117(7):971-5. PubMed ID: 4759834
    [No Abstract]   [Full Text] [Related]  

  • 46. Intrauterine administration of human chorionic gonadotropin does not improve pregnancy and life birth rates independently of blastocyst quality: a randomised prospective study.
    Wirleitner B; Schuff M; Vanderzwalmen P; Stecher A; Okhowat J; Hradecký L; Kohoutek T; Králícková M; Spitzer D; Zech NH
    Reprod Biol Endocrinol; 2015 Jul; 13():70. PubMed ID: 26141379
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma LH-HCG, 17 -estradiol, estrone and progesterone monitoring around ovulation and subsequent nidation.
    Thomas K; De Hertogh R; Pizarro M; Van Exter C; Ferin J
    Int J Fertil; 1973; 18(2):65-73. PubMed ID: 4353919
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Abdominal ectopic pregnancy with undetectable serum β-human chorionic gonadotropin 9 days following blastocyst transfer.
    Irani M; Elias RT; Pereira N; Gunnala V; Rosenwaks Z
    J Obstet Gynaecol Res; 2016 Dec; 42(12):1886-1888. PubMed ID: 27718286
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fertility regulation technology: status and prospects.
    Segal SJ; Nordberg OS
    Popul Bull; 1977 Mar; 31(6):1-25. PubMed ID: 12335682
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does implantation occur in the presence of an IUD?
    Saxena BB; Landesman R
    Res Reprod; 1978 May; 10(3):1-2. PubMed ID: 674811
    [No Abstract]   [Full Text] [Related]  

  • 53. Semiquantitative use of Biocept-G radioreceptorassay.
    Hussa RO; Mattingly RF
    Obstet Gynecol; 1979 Aug; 54(2):199-204. PubMed ID: 460754
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fertilisation in women with intrauterine devices.
    Nilsson CG; Lähteenmäki P
    Lancet; 1977 Nov; 2(8048):1126. PubMed ID: 73026
    [No Abstract]   [Full Text] [Related]  

  • 55. Unsuspected pregnancy loss in healthy women.
    Whittaker PG; Taylor A; Lind T
    Lancet; 1983 May; 1(8334):1126-7. PubMed ID: 6133154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Natural limits of pregnancy testing in relation to the expected menstrual period.
    Wilcox AJ; Baird DD; Dunson D; McChesney R; Weinberg CR
    JAMA; 2001 Oct; 286(14):1759-61. PubMed ID: 11594902
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Abortifacient effect of intrauterine contraceptive devices?
    Keller PJ; Soyka E
    Gynecol Invest; 1978; 9(4):219-21. PubMed ID: 750328
    [No Abstract]   [Full Text] [Related]  

  • 58. Systematic Review of Postfertilization Effects and Potential for Embryo Formation and Loss during the Use of Intrauterine Devices.
    Buskmiller C; Harrison D; Ruppersberger LA; Yeung PP
    Linacre Q; 2020 Feb; 87(1):60-77. PubMed ID: 32431449
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of a copper intrauterine device during the early stages of pregnancy in the rabbit.
    Nutting EF; Mueller MR
    Fertil Steril; 1975 Aug; 26(8):838-44. PubMed ID: 1157967
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The scanning electronmicroscopy of human cervical mucus in the non-pregnant and pregnant states.
    Daunter B; Chantler EN; Elstein M
    Br J Obstet Gynaecol; 1976 Sep; 83(9):738-43. PubMed ID: 974053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.